HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Paradox”

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 5, 2016-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients

By Donato Maria Francesca   Bastiampillai Anan Judina   Manini Matteo   Monico Sara  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 974-975

Oxford University Press

Access to resources Recommend Favorite

The Effect of Unsuccessful Treatment with Peginterferon and Ribavirin on the Liver Fibrosis Course of HIV/HCV-Coinfected Patients

By  

Current HIV Research, Vol. 10, Iss. 8, 2012-12 ,pp. : 679-687

Bentham Science Publishers

Access to resources Recommend Favorite

Liver-Related Factors Associated with Low Vitamin D Levels in HIV and HIV/HCV Coinfected Patients and Comparison to General Population

By  

Current HIV Research, Vol. 9, Iss. 3, 2011-04 ,pp. : 186-193

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: A case-control study

By Hatzakis A.   Katsoulidou A.   Kaklamani E.   Touloumi G.   Koumantaki Y.   Tassopoulos N.   Karvountzis G.   Gioustozi A.   Hadziyannis S.   Trichopoulos D.  

International Hepatology Communications, Vol. 7, Iss. 1, 1997-05 ,pp. : 66-66

Elsevier

Access to resources Recommend Favorite